Tarun Puri

7PUBLICATIONS
48CO-AUTHORS
Molecular targetsCancer diagnosisEpidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 02, 2026
SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy.

|Sep 15, 2026
Real-World Treatment Patterns and Clinical Outcomes After First-Line Therapy in Patients with KRAS G12C-Mutant Advanced Non-Small-Cell Lung Cancer in the United States.

|May 11, 2026
Structured Expert Elicitation of Long-Term Survival in Non-small Cell Lung Cancer: A Case Study Applying Guidance from NICE Technical Support Document 26.

|Apr 29, 2026
Efficacy of selpercatinib as a first-line treatment for RET-fusion positive non-small-cell lung cancer: a novel two-stage Bayesian network meta-analysis.

|Jun 03, 2025
Matching-adjusted indirect comparison of selpercatinib and pralsetinib in RET fusion-positive non-small cell lung cancer.

Maximilian Hochmair, Urpo Kiiskinen, Yulia D'yachkova

|Jun 03, 2024
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer.

Maurice Pérol, Benjamin J Solomon, Koichi Goto

Pageof 2

Frequent Collaborators

3 joint publications

Ernest Nadal

2 joint publications

Min-Hua Jen

2 joint publications

Jessica E Forsyth

2 joint publications

Yulia D'yachkova